Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Hair follicles help attract immune cells to the skin during stress.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

Human mesenchymal stem cells show promise for treating skin diseases, but more research is needed to improve treatments.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

A woman with lupus and severe nerve damage improved with specific treatments.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

UV light helped human hair transplants survive in mice without broad immunosuppression.

JAK inhibition reduces autoimmune issues in Down syndrome.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Intralesional corticosteroids effectively treat localized alopecia areata, often sparing white hairs.

Adipose-derived stem cells are promising for regenerative medicine due to their accessibility, versatility, and low risk of immune rejection.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Alopecia areata involves unique activation of certain immune cells.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Autoimmune reactions may cause both alopecia areata and HAM.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Examining Survivin levels may help understand premature greying of hair.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

CXCR3+ T cells and B cells drive skin disease and hair loss in lupus, with potential targets identified for treatment.

A new microneedle treatment shows promise for repigmenting skin in vitiligo.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Alopecia areata is linked to reduced T cell function and auto-immunity.

ILC1-like cells may contribute to hair loss in alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

ILC1-like cells can cause alopecia areata by affecting hair follicles.